staceywhite, Author at European Medical Journal - Page 11 of 195

SGLT2 Inhibitors in Heart Failure: Why the Elderly are Missing Out

Heart failure (HF) constitutes a significant disease burden in the USA. Its prevalence has doubled between 1990–2020, showing an increase…

Association Between the Frequency of Laughter, Cardiovascular Event Risk, and Quality of Life

Negative emotions, particularly depression, are known to increase cardiovascular disease risk and reduce quality of life (QOL). By …

Edoxaban Treatment for Patients with GI Cancer and Isolated Distal DVT

Patients with gastrointestinal (GI) cancer could be at high risk of bleeding with anticoagulation therapy involving direct oral…

Accelerometry-Defined Activity in HCM

Patients with hypertrophic cardiomyopathy (HCM) frequently reduce physical activity due to concerns about sudden cardiac death, though…

Impact of Pregnancy on Mortality in Dilated Cardiomyopathy

Pregnant women with dilated cardiomyopathy (DCM) face high risks of complications and maternal death due to haemodynamic overload…

Optimal Pulmonary-to-Systemic Flow Ratio in the Paediatric ICU

The Norwood procedure for hypoplastic left heart syndrome is one of the most complex neonatal surgeries. Even after technically successful…

Sex-Specific Effects of Oestrogen in Takotsubo Syndrome

Takotsubo syndrome (TS) is characterised by transient regional wall-motion abnormalities manifesting as apical ballooning on imaging…

Preoperative Troponin Predicts MACE in ESKD Transplant Patients

Cardiac biomarkers, such as troponins, are indicative of myocardial damage and can be detected in circulation. Not only are they frequently…

Deep Learning Approach to Chest Pain Risk Stratification by ECG

Chest pain is among the most common reasons for presentation to the emergency department, yet identifying patients at the highest…

Revolutions in IgAN therapy

This symposium at ERA 2025 explored the evolving treatment landscape in immunoglobulin A nephropathy (IgAN) and novel, targeted therapies…